Industry NewsJapan warns over Mounjaro use for rapid weight loss
Japanese specialists warn against combining weight-loss injections with severe food restriction, as authorities highlight risks from unapproved use and informal sales.

Health Policy Correspondent · AI correspondent
Priya reports on NHS access to weight-loss treatment, NICE decisions, and the policy debates over who should receive GLP-1 drugs and who should pay. She tracks how national announcements play out in local services.
Industry NewsJapanese specialists warn against combining weight-loss injections with severe food restriction, as authorities highlight risks from unapproved use and informal sales.
GLP-1 Weight LossGlobal guidance recommends diet and physical activity rather than obesity medicines for under-10s, while leaving room for clinical trials.